Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Perrigo Company (PRGO) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 9,743,425
  • Shares Outstanding, K 143,370
  • Annual Sales, $ 2,770 M
  • Annual Income, $ 6 M
  • 36-Month Beta 0.67
  • Price/Sales 1.73
  • Price/Cash Flow N/A
  • Price/Book 1.13

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.86 +3.71%
on 03/27/17
76.88 -9.81%
on 02/28/17
-15.34 (-18.12%)
since 02/27/17
3-Month
66.86 +3.71%
on 03/27/17
87.48 -20.74%
on 01/04/17
-15.84 (-18.60%)
since 12/27/16
52-Week
66.86 +3.71%
on 03/27/17
133.53 -48.07%
on 04/07/16
-60.97 (-46.79%)
since 03/24/16

Most Recent Stories

More News
Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll Holdings plc, Momenta Pharmaceuticals, Inc., Omnicom Group Inc., Perrigo Company plc, Santander Consumer USA Holdings Inc. and The Interpublic Group of Companies, Inc.

Aratana Therapeutics, Inc. (PETX)

SC : 12.88 (-0.62%)
INNL : 1.00 (-2.91%)
IPG : 24.08 (-0.33%)
OMC : 84.29 (-0.05%)
MNTA : 13.80 (+1.85%)
PETX : 5.15 (+1.98%)
PRGO : 69.02 (+1.56%)
Perrigo Provides Update On 2016 Form 10-K Filing

Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Healthcare Products®, today commented, "We continue to make progress with our independent auditor, Ernst & Young ("E&Y"),...

PRGO : 69.02 (+1.56%)
Perrigo Set to Possibly Pullback After Yesterday's Rally of 1.13%

Perrigo (NASDAQ:PRGO) traded in a range yesterday that spanned from a low of $70.36 to a high of $71.55. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $70.68...

PRGO : 69.02 (+1.56%)
Perrigo Launches First to Market OTC Equivalent of Rogaine

Perrigo Company plc (PRGO) announced the first-to-market launch of the over-the-counter ("OTC") version of hair re growth drug for the brand equivalent of women's Rogaine 5% minoxidil foam (minoxidil topical...

HSKA : 98.67 (-0.05%)
AGTC : 6.65 (unch)
SNSS : 4.21 (+2.43%)
PRGO : 69.02 (+1.56%)
Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent To Women's Rogaine® Foam

Perrigo Company plc (NYSE; TASE: PRGO) today announced the first-to-market launch of the over-the-counter ("OTC") store brand equivalent to Women's Rogaine® 5% minoxidil foam (minoxidil topical aerosol,...

PRGO : 69.02 (+1.56%)
After Yesterday's Decline of 2.31%, Perrigo Offers Investors Better Value

Perrigo (NASDAQ:PRGO) traded in a range yesterday that spanned from a low of $70.94 to a high of $72.74. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $72.12 on...

PRGO : 69.02 (+1.56%)
Pawar Law Group Announces Investigation of Securities Claims Against Perrigo Company plc - PRGO

NEW YORK, NY / ACCESSWIRE / March 1, 2017 / The Pawar Law Group announces that it is investigating potential securities claims on behalf of shareholders of Perrigo Company plc (NYSE: PRGO) resulting from...

PRGO : 69.02 (+1.56%)
Covered Call reports for 3D Systems, Metlife Incorporated, Pandora, Perrigo Co. and ZTO Express include trade ideas that offer returns of 21% or more!

InvestorsObserver issues critical PriceWatch Alerts for DDD, MET, P, PRGO, and ZTO.

ZTO : 12.59 (-0.63%)
DDD : 14.10 (-0.49%)
MET : 51.60 (-0.79%)
PRGO : 69.02 (+1.56%)
Perrigo to Sell Tysabri Royalties; Issues Tepid 2017 View

The company also announced that it has signed an agreement to divest the royalties it receives in multiple sclerosis drug, Tysabri, in order to monetize the asset.

CELG : 125.92 (+2.06%)
SNSS : 4.21 (+2.43%)
PRGO : 69.02 (+1.56%)
BIIB : 274.74 (-0.03%)
Perrigo Company plc Reports Select Preliminary Unaudited Calendar Year 2016 Financial Results And Initial Calendar Year 2017 Guidance

-- Delivered preliminary unaudited calendar year 2016 record reported net sales of $5.6 billion and adjusted net sales of $5.5 billion

PRGO : 69.02 (+1.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United...

See More

Support & Resistance

2nd Resistance Point 68.91
1st Resistance Point 68.43
Last Price 69.02
1st Support Level 67.64
2nd Support Level 67.33

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.